Previous Article
Clinical and Vaccine Immunology, January 2008, p. 172-175, Vol. 15, No. 1
1071-412X/08/$08.00+0 doi:10.1128/CVI.00292-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Detection of Human Papillomavirus Type 31-Neutralizing Antibodies from Naturally Infected Patients by an Assay Based on Intracellular Assembly of Luciferase-Expressing Pseudovirions
Maxime J. J. Fleury,1,2,3
Antoine Touzé,1,2,3
Silvia de Sanjosé,4
F. Xavier Bosch,4
Joellen Klaustermeiyer,4 and
Pierre Coursaget1,2,3*
INSERM U618, Tours, France,1
University François Rabelais, Tours, France,2
IFR 136, Agents Transmissibles et Infectiologie, Faculté des Sciences Pharmaceutiques, Tours, France,3
Servei d'Epidemiologia i Registre del Cancer, Institut Catala d'Oncologia, Barcelona, Spain4
Received 4 July 2007/
Returned for modification 28 August 2007/
Accepted 29 October 2007
The aim of this study was to develop a highly sensitive human papillomavirus type 31 (HPV31) neutralization assay based on the production of pseudovirions carrying luciferase. Neutralizing antibodies against HPV31 were investigated in a set of HPV31 monoclonal antibodies and in women with evidence of HPV31 infection. Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay.
* Corresponding author. Mailing address: Laboratoire Vecteurs, Virus & Vaccins, INSERM U618, Faculté des Sciences Pharmaceutiques, 31 Ave. Monge, 37200 Tours, France. Phone: 33 2 47 36 72 56. Fax: 33 2 47 36 71 88. E-mail:
coursaget{at}univ-tours.fr
Published ahead of print on 7 November 2007.
Clinical and Vaccine Immunology, January 2008, p. 172-175, Vol. 15, No. 1
1071-412X/08/$08.00+0 doi:10.1128/CVI.00292-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Randhawa, P., Viscidi, R., Carter, J. J., Galloway, D. A., Culp, T. D., Huang, C., Ramaswami, B., Christensen, N. D.
(2009). Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J. Gen. Virol.
90: 634-639
[Abstract]
[Full Text]
-
Bousarghin, L., Touze, A., Gaud, G., Iochmann, S., Alvarez, E., Reverdiau, P., Gaitan, J., Jourdan, M.-L., Sizaret, P.-Y., Coursaget, P. L.
(2009). Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Molecular Cancer Therapeutics
8: 357-365
[Abstract]
[Full Text]
-
Steele, J., Collins, S., Wen, K., Ryan, G., Constandinou-Williams, C., Woodman, C. B. J.
(2008). Measurement of the Humoral Immune Response following an Incident Human Papillomavirus Type 16 or 18 Infection in Young Women by a Pseudovirion-Based Neutralizing Antibody Assay. CVI
15: 1387-1390
[Abstract]
[Full Text]